JAK2 and myeloproliferative neoplasm: FERM‐JAK2+ recipient mice developed signs of MPN similar to JAK2‐V617F‐induced disease with increased WBC, hematocrit, hemoglobin and granulocytes in peripheral blood (Fig. S6A,B).